School of Medicine


Showing 551-560 of 641 Results

  • John Mark Gubatan, MD

    John Mark Gubatan, MD

    Instructor, Medicine - Gastroenterology & Hepatology

    BioDr. Gubatan is a physician scientist, board-certified gastroenterologist, and instructor of medicine at Stanford University School of Medicine. He earned his medical degree from Harvard Medical School and completed his internship and residency in internal medicine at Harvard's Beth Israel Deaconess Medical Center. He completed his gastroenterology fellowship at Stanford where he served as chief fellow and was an American Gastroenterological Association (AGA) editorial fellow for Gastroenterology. Dr. Gubatan’s research is focused on translational studies using single-cell multi-omics to understand mechanisms of therapy failure, elucidate the role of host immune and gut microbiome interactions in the pathogenesis of inflammatory bowel disease (IBD), and develop precision medicine strategies to improve outcomes in patients with IBD. Dr. Gubatan’s work has been featured in Gastroenterology, Gut, American Journal of Gastroenterology, Clinical Gastroenterology and Hepatology, Alimentary Pharmacology and Therapeutics, Journal of Crohns & Colitis, and Inflammatory Bowel Diseases. Dr. Gubatan's research and career development has been supported by a Chan Zuckerberg Biohub Physician Scientist Scholar Award, a Stanford Translational Research and Applied Medicine (TRAM) Scholar Award, an NIH NIDDK LRP Award, and a Doris Duke Charitable Foundation Physician Scientist Fellowship Award.

  • Brandon Alan Guenthart

    Brandon Alan Guenthart

    Clinical Assistant Professor, Cardiothoracic Surgery

    BioDr. Guenthart is a board-certified, fellowship-trained cardiothoracic surgeon. He is a clinical assistant professor in the Department of Cardiothoracic Surgery.

    He specializes in providing leading-edge surgical treatment for people with cancer and end-stage heart and lung disease. He performs the full range of surgical procedures ranging from minimally invasive thoracic surgery to heart and lung transplantation. Dr. Guenthart practices all aspects of thoracic surgery, including procedures for benign and malignant conditions of the airway, lung, mediastinum, esophagus, and foregut. He has a particular interest in minimally invasive techniques and has extensive experience in video-assisted thoracoscopic surgical (VATS), laparoscopic, robotic, endoscopic, and bronchoscopic approaches.

    Dr. Guenthart earned his medical degree at Temple University School of Medicine. He completed general surgery residency at Cornell and a post-doctoral research fellowship in tissue bioengineering at Columbia University in the Laboratory for Stem Cells and Tissue Engineering. He then completed cardiothoracic surgery fellowship and advanced fellowship training in cardiothoracic transplantation and mechanical circulatory support at Stanford University.

    Dr. Guenthart has conducted research supported by grants from the National Institutes of Health, Stanford University School of Medicine, and Columbia University. Dr. Guenthart has a particular interest in end-stage lung disease and his research focuses on lung perfusion and bioengineering strategies to promote lung recovery and regeneration. He has published in peer-reviewed journals such as Nature Medicine, Nature Biomedical Engineering, the Journal of Heart and Lung Transplantation. He has made numerous presentations to his peers at national conferences and given invited talks on patient selection, organ allocation, and other aspects of transplantation.

    Dr. Guenthart is a member of the Society of Thoracic Surgeons, Western Thoracic Surgical Association, Biomedical Engineering Society, American College of Surgeons, Association for Academic Surgery, and Alpha Omega Alpha Medical Honor Society.

  • Thomas Guenther

    Thomas Guenther

    Postdoctoral Scholar, Molecular Imaging Program at Stanford

    Current Research and Scholarly InterestsCurrent research projects include the development of:
    1) Gastrin-releasing peptide receptor (GRPR) targeted radiotheranostics (Cu-64, Ga-68, Tb-161, Lu-177, amongst others)
    2) Radiohybrid-based cholecystokinin-2 receptor (CCK-2R) targeted radiotheranostics (F-18, Lu-177)
    3) Radiotherapeutics for targeted alpha-particle therapy
    4) Radiotheranostics for novel targets
    All projects have a strong focus on clinical translation

  • Allison Guerin

    Allison Guerin

    Senior Director of Education and Diversity, Equity, Inclusion & Justice, Pediatrics

    Current Role at StanfordSenior Director of Education and Diversity, Equity, Inclusion & Justice, Department of Pediatrics